The S-Network Medical Indexes are designed to serve as fair, impartial and transparent measures of the performance of medical equities. There are currently three indexes in the S-Network Medical Index family:
S-Network Medical Indexes represent breakthroughs in “smart beta” index methodologies. S-Network Medical Indexes apply metrics that are specific to biotechnology and pharmaceuticals and are not applicable to other sectors or industries, resulting in highly idiosyncratic performance characteristics.
S-Network Medical Indexes focus on companies that are principally engaged in the US health care sector, with strong emphasis on the dynamic small/mid-capitalization biotechnology segment.
All S-Network Medical Indexes depend on clearly defined rules based methodologies, which are overseen by an impartial Index Committee. No discretion is exercised in compiling the indexes and a pre-defined screening protocol assures a consistent, transparent and arms-length compilation process.